University of Nottingham

University of Nottingham

Pre-Clinical Oncology

Research in the Division is translational and involves strong collaborations with clinicians and industry. Current research areas include: use of reporter constructs for the imaging of key biological parameters within tumours, such as growth, apoptosis, angiogenesis and metastatic pathways and stem cell evolution; modelling the tumour microenvironment including the process of epithelial-mesenchymal transition; analysis of paracrine interactions in tumour progression including HGF/c-met, hedgehog, and fibroblast growth factors; delivery of siRNAs using non-viral and viral delivery systems for target validation; pre-clinical validation/target identification of traditional Chinese medicines; contribution of ß-catenin controlled intestinal stem-cell associated homeodomain transcription factors to carcinogenesis and the involvement of the tumour suppressor gene, FBW7 a ubiquitin ligase, in intestinal malignant progression.

Course modules

Assessment methods

Qualifications

Qualification Study mode Start month Fee Course duration
MRes Full-time September 2017 - 2 years
MRes Part-time September 2017 - 4 years

Campus details

Campus name Town Postcode Region Main campus Campus Partner
Queen's Medical Centre Nottingham NG7 2HA East Midlands

Get in touch

Remember to mention TARGETpostgrad when contacting universities.

Key information

Contact: 
Postgraduate Enquiries
Telephone number: 
+44 (0) 115 951 5559